$122.51
-2.02[-1.62%]
At close: Apr 18
$122.51
0[0.00%]
After Hours: 7:00PM EDT
Novo Nordisk reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Novo Nordisk using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/02/2024 | AM | NVO | Q1 | $0.64 | $0.79 | — | — | $7.69B | $9.71B | — | — | Get Alert |
01/31/2024 | AM | NVO | Q4 | $0.41 | $0.65 | $0.71 | 9.08% | $6.44B | $8.82B | $9.50B | 7.75% | Get Alert |
11/02/2023 | AM | NVO | Q3 | $0.43 | $0.71 | $0.73 | 2.82% | $6.17B | $7.91B | $8.58B | 8.42% | Get Alert |
08/10/2023 | AM | NVO | Q2 | $0.42 | $0.64 | $0.63 | -1.56% | $5.91B | $7.97B | $7.94B | -0.39% | Get Alert |
05/04/2023 | AM | NVO | Q1 | $0.47 | $0.64 | $0.64 | 0.00% | $6.34B | $7.65B | $7.69B | 0.55% | Get Alert |
02/01/2023 | AM | NVO | Q4 | $0.37 | $0.43 | $0.41 | -4.65% | $5.90B | $6.84B | $6.44B | -5.91% | Get Alert |
11/02/2022 | AM | NVO | Q3 | $0.42 | $0.42 | $0.43 | 2.38% | $5.64B | $5.89B | $6.17B | 4.82% | Get Alert |
08/03/2022 | AM | NVO | Q2 | $0.43 | $0.41 | $0.42 | 2.44% | $5.32B | $5.81B | $5.91B | 1.76% | Get Alert |
04/29/2022 | AM | NVO | Q1 | $0.44 | $0.40 | $0.47 | 17.50% | $5.48B | $5.59B | $6.34B | 13.43% | Get Alert |
02/02/2022 | AM | NVO | Q4 | $0.32 | $0.36 | $0.37 | 2.78% | $5.14B | $5.67B | $5.90B | 3.99% | Get Alert |
11/03/2021 | AM | NVO | Q3 | $0.35 | $0.39 | $0.42 | 7.69% | $4.86B | $5.35B | $5.64B | 5.51% | Get Alert |
08/05/2021 | AM | NVO | Q2 | $0.34 | $0.39 | $0.43 | 10.26% | $4.43B | $5.11B | $5.32B | 4.15% | Get Alert |
05/05/2021 | AM | NVO | Q1 | $0.38 | $0.42 | $0.44 | 4.76% | $5.08B | $5.29B | $5.48B | 3.59% | Get Alert |
02/03/2021 | AM | NVO | Q4 | $0.28 | $0.32 | $0.32 | 0.00% | $4.86B | $5.35B | $5.14B | -3.89% | Get Alert |
10/30/2020 | AM | NVO | Q3 | $0.32 | $0.36 | $0.35 | -2.78% | $4.54B | $4.89B | $4.86B | -0.70% | Get Alert |
08/06/2020 | AM | NVO | Q2 | $0.31 | — | $0.34 | — | $4.51B | — | $4.43B | — | Get Alert |
05/06/2020 | AM | NVO | Q1 | $0.33 | — | $0.38 | — | $4.39B | — | $5.08B | — | Get Alert |
02/05/2020 | AM | NVO | Q4 | $0.27 | $0.28 | $0.28 | 0.00% | $4.55B | $4.76B | $4.86B | 2.16% | Get Alert |
11/01/2019 | AM | NVO | Q3 | $0.29 | $0.31 | $0.32 | 3.23% | $4.33B | $4.54B | $4.54B | 0.04% | Get Alert |
Novo Nordisk (NVO) is scheduled to report earnings on May 2, 2024. The last reported earnings were for reported on January 31, 2024 for Q4.
The Actual EPS was $0.71, which beat the estimate of $0.65.
The Actual Revenue was $9.5B, which beat the estimate of $8.8B.
Browse earnings estimates, EPS, and revenue on all stocks.